Primary cutaneous anaplastic large cell lymphoma
MONDO:0017598Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a rare T-cell non-Hodgkin lymphoma that affects the skin and generally shows no extracutaneous involvement at presentation. It belongs to the spectrum of primary cutaneous CD30+ lymphoproliferative disorders along with lymphomatoid papulosis with which it shares overlapping clinical and histopathologic features.
Also known as: ALCL, cutaneous, C-ALCL, anaplastic large-cell lymphoma, primary cutaneous type, primary C-ALCL, primary anaplastic large cell lymphoma of skin, primary anaplastic large cell lymphoma of the skin, primary cutaneous CD30 Positive anaplastic large cell lymphoma, primary cutaneous CD30+ ALCL
3154 clinical trials for this condition and its sub-types, 11 tagged with Primary cutaneous anaplastic large cell lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Supercharged T-Cells take on stubborn lymphomas
Disease control Recruiting nowThis early-stage trial is testing a new type of immunotherapy for people with CD30-positive blood cancers that have come back or not responded to treatment. The therapy uses a patient's own immune cells, which are collected, modified with a special antibody, and then given back t…
Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Vitamin a derivative takes on tough lymphoma
Disease control Recruiting nowThis early-stage trial is testing a new form of fenretinide (a vitamin A-like drug) given by IV for people with T-cell non-Hodgkin lymphoma that has come back or stopped responding to treatment. The study has two parts: first, finding the safest dose in small groups of patients, …
Phase 1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Massive T-Cell lymphoma database aims to unlock new insights
Knowledge-focused Recruiting nowThis study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists investigate skin microbiome in rare lymphoma
Knowledge-focused Recruiting nowThis study looks at the bacteria living on the skin of people with cutaneous T cell lymphoma, a rare type of skin cancer. Researchers will compare these bacteria to those on healthy people and people with other skin conditions like psoriasis. The goal is to understand if certain …
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC